Incremental Prognostic Value of Myocardial Fibrosis in Patients With Non–Ischemic Cardiomyopathy Without Congestive Heart Failure

Author:

Masci Pier Giorgio1,Doulaptsis Constantinos1,Bertella Erika1,Del Torto Alberico1,Symons Rolf1,Pontone Gianluca1,Barison Andrea1,Droogné Walter1,Andreini Daniele1,Lorenzoni Valentina1,Gripari Paola1,Mushtaq Saima1,Emdin Michele1,Bogaert Jan1,Lombardi Massimo1

Affiliation:

1. From the Cardiovascular Magnetic Resonance Department (P.G.M., M.L.), and the Cardiology Department (A.B., A.D.T., M.E.), Fondazione CNR/Regione Toscana “G. Monasterio,” Pisa, Italy; Departments of Radiology (C.D., R.S., J.B.) and Cardiology (W.D.), Gasthuisberg University Hospital, Leuven, Belgium; Centro Cardiologico Monzino, Milano, Italy (E.B., G.P., D.A., P.G., S.M.); Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy (D.A.); and...

Abstract

Background— We conducted a prospective longitudinal study to investigate the yet unknown clinical significance of myocardial fibrosis in patients with non–ischemic cardiomyopathy without history of congestive heart failure (CHF). Methods and Results— At 3 tertiary referral centers, 228 patients with non–ischemic cardiomyopathy without history of CHF were studied with cardiovascular magnetic resonance for late gadolinium enhancement (LGE) detection and quantification and prospectively followed up for a median of 23 months. The end point was a composite of cardiac death, onset of CHF, and aborted sudden cardiac death. LGE was detected in 61 (27%) patients. Thirty-one of 61 (51%) patients with LGE reached combined end point when compared with 18 of 167 (11%) patients without LGE (hazard ratio, 5.10 [2.78–9.36]; P <0.001). Patients with LGE had greater risk of developing CHF than patients without LGE (hazard ratio, 5.23 [2.61–10.50]; P <0.001) and higher rate of aborted sudden cardiac death (hazard ratio, 8.31 [1.66–41.55]; P =0.010). Multivariate analysis showed that LGE was associated with high likelihood of composite end point independent of other prognostic determinants, including age; duration of cardiomyopathy; and left ventricular volumes, mass, and ejection fraction (hazard ratio, 4.02 [2.08–7.76]; P <0.001). Improvement χ 2 analysis disclosed that LGE addition to models, including clinical data alone or in combination with parameters of left ventricular remodeling and function, yielded an improvement in outcome prediction ( P <0.001). Addition of LGE to age and left ventricular ejection fraction improved risk stratification for composite end point (net reclassification improvement, 29.6%) and onset of CHF (net reclassification improvement, 25.4%; both P <0.001). Conclusions— In patients with non–ischemic cardiomyopathy without history of CHF, myocardial fibrosis is a strong and independent predictor of outcome, providing incremental prognostic information and improvement in risk stratification beyond clinical data and degree of left ventricular dysfunction.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3